Biodexa Pharmaceuticals

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals (formerly Midatech) is a clinical-stage biopharmaceutical company focused on oncology and rare and orphan indications.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

$17.0m

Grant
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2016201720182019202020212022
Revenues0000000000000000000000000000
EBITDA0000000000000000000000000000
% EBITDA margin--(1000 %)----
Profit0000000000000000000000000000
% profit margin--(1500 %)----
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Biodexa Pharmaceuticals

Edit
Q Chip
ACQUISITION by Biodexa Pharmaceuticals Dec 2014
DARA BioSciences
ACQUISITION by Biodexa Pharmaceuticals Jun 2015